Latest filing published 21 Jul 2025 for UV GERMI, €27k. Read the official filing
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Willy Fortunato in UV Germi, where the filings describe the role as chief executive. Over a trading history stretching from 28 January 2022 to 23 June 2025, the count stands at 6 filings.
Purchases make up the whole of the open-market record (3 purchases, €191k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants.
In size, the median ticket on the buying side is €75k. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days. After 3 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -34.3%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 21 July 2025, reports a share grant of €27k in UV Germi. The clock since the last published purchase (13 July 2023) now reads 1,192 days. Filings reach the AMF feed a median of 6 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from AMF. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations